Donepezil Hydrochloride; Memantine Hydrochloride Capsule, Extended Release — FDA Drug Shortage

To Be Discontinued — Amneal Pharmaceuticals

The FDA lists a drug shortage record for Donepezil Hydrochloride; Memantine Hydrochloride Capsule, Extended Release (capsule, extended release) from Amneal Pharmaceuticals with status To Be Discontinued. The shortage was first posted on 06/15/2026.

Shortage Details

Status
To Be Discontinued
Company
Amneal Pharmaceuticals
Package NDC
69238-1248-3
Dosage Form
Capsule, Extended Release
Presentation
Donepezil Hydrochloride; Memantine Hydrochloride, Capsule, Extended Release, 10 mg; 14 mg (NDC 69238-1248-3)
Initial Posting
06/15/2026
Revised Date